Molecular Genetic Basis of Williams Syndrome
威廉姆斯综合征的分子遗传学基础
基本信息
- 批准号:6919204
- 负责人:
- 金额:$ 38.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-06-01 至 2007-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by the applicant): Williams Syndrome (WS) is an autosomal
dominant genetic condition characterized by an ensemble of physical, cognitive,
and behavioral traits. The syndrome has been mapped to 7ql1.23, where genetic
causation is attributed to a microdeletion of approximately 1.5 Mb in length.
To date, 17 genes have been identified in the haplo-insufficiency region, which
serve as specific candidates for the multiple features of the condition. While
the 1.5 Mb deletion occurs most commonly, smaller more informative deletions
occur at a lower frequency and facilitate the presumptive identification of
genes that are causal to specific cranio-facial and neurological attributes of
WS. Currently, deletion mapping implicates genes near the telomeric terminus of
the deletion, as most critical in phenotype causation. Three genes are viable
candidates. These are CLIP-115, BEN, and TFII-I. CLIP-115 is a cytoplasmic
linker protein, while TFII-I and BEN are closely related helix-loop-helix
transcription factors. We have recently isolated the BEN gene in mice in a
search for factors that bind to the early enhancer of the developmentally
important Hoxc8 gene. This implicates BEN and TFII-I as candidate developmental
factors, deficiencies of which may be expected to generate the symptomology of
WS. In an effort to establish the molecular basis of WS, we will use chromosome
engineering and other transgenic methodologies to simulate a
haplo-insufficiency for these three candidate genes in mice. The mutant mice
will be examined for physical, biochemical, and behavioral phenotypes that are
typical of persons with WS. In this way, we hope to implicate definitively the
three candidate genes singly or in combination as casual factors in WS. This
will represent the first step in establishing the molecular genetic basis of
WS. The second step will involve the discovery of downstream genes regulated by
the transcription factors BEN and TFII-I. We believe certain genes in this
category may be profoundly deregulated in the WS haplo-insuficiency condition,
and are therefore most probably the immediate causal factors in WS. The
establishment of the developmental genetic basis of WS is important beyond the
understanding it brings to WS itself. The identification of genes that regulate
behavior allows further investigation of genetic polymorphisms of these genes
that may be causal to less severe behavioral conditions or to variations in
behavior within a range considered normal.
描述(由申请方提供):威廉姆斯综合征(WS)是一种常染色体
显性遗传条件的特点是一个整体的身体,认知,
和行为特征该综合征已被定位于7ql1.23,其中遗传
其原因归因于长度约1.5 Mb的微缺失。
到目前为止,在单倍不足区域已经鉴定出17个基因,
作为条件的多个特征的特定候选者。而
1.5 Mb缺失最常见,更小的缺失信息量更大
以较低的频率发生,并有助于推定识别
基因是导致特定的颅面和神经属性,
目前,缺失作图涉及端粒末端附近的基因,
缺失,作为表型因果关系中最关键的。三个基因是可行的
候选人这些是CLIP-115、BEN和TFII-I。CLIP-115是一种细胞质
连接蛋白,而TFII-I和BEN是密切相关的螺旋-环-螺旋
转录因子我们最近在一个实验中分离出了小鼠的BEN基因。
寻找与发育早期增强因子结合的因子,
Hoxc 8基因。这意味着BEN和TFII-I是候选的发展
这些因素的缺陷可能会导致
为了建立WS的分子基础,我们将使用染色体
工程和其他转基因方法来模拟
这三个候选基因在小鼠中的单倍不足。突变小鼠
将检查身体,生化和行为表型,
典型的WS患者。通过这种方式,我们希望明确地暗示
三个候选基因单独或组合作为WS的因果因子。
将代表建立遗传学分子基础的第一步,
第二步将涉及发现下游基因的调控,
转录因子BEN和TFII-I。我们认为这其中的某些基因
在WS单倍缺陷条件下,
因此,最有可能是WS的直接因果因素。
建立WS的发育遗传基础是重要的,
理解它给WS本身带来的影响。识别调控基因
行为允许进一步调查这些基因的遗传多态性
这可能是不太严重的行为条件或变化的原因,
在正常范围内的行为。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANK H RUDDLE其他文献
FRANK H RUDDLE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANK H RUDDLE', 18)}}的其他基金
PREDOCTORAL TRAINING PROGRAM IN DEVELOPMENTAL BIOLOGY
发育生物学博士前培训计划
- 批准号:
6329814 - 财政年份:1995
- 资助金额:
$ 38.83万 - 项目类别:
PREDOCTORAL TRAINING PROGRAM IN DEVELOPMENTAL BIOLOGY
发育生物学博士前培训计划
- 批准号:
6079271 - 财政年份:1995
- 资助金额:
$ 38.83万 - 项目类别:
PREDOCTORAL TRAINING PROGRAM IN DEVELOPMENTAL BIOLOGY
发育生物学博士前培训计划
- 批准号:
6476621 - 财政年份:1995
- 资助金额:
$ 38.83万 - 项目类别:
相似海外基金
Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
- 批准号:
22K09003 - 财政年份:2022
- 资助金额:
$ 38.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
- 批准号:
21K07762 - 财政年份:2021
- 资助金额:
$ 38.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
- 批准号:
20K16927 - 财政年份:2020
- 资助金额:
$ 38.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
- 批准号:
20H00526 - 财政年份:2020
- 资助金额:
$ 38.83万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
- 批准号:
20K21245 - 财政年份:2020
- 资助金额:
$ 38.83万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
- 批准号:
G0900887/1 - 财政年份:2011
- 资助金额:
$ 38.83万 - 项目类别:
Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
- 批准号:
05558090 - 财政年份:1993
- 资助金额:
$ 38.83万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
- 批准号:
04453031 - 财政年份:1992
- 资助金额:
$ 38.83万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)














{{item.name}}会员




